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Comparative proteomic analysis of extracellular 
matrix proteins secreted by hypertrophic scar 
with normal skin fibroblasts
Introduction
In general, a wound repair process occurs in almost all tissues 
after the exposure to any destructive stimulus and is one of the 
most complex biological processes. Hypertrophic scars (HSs), 
a special fibrosis caused by an injury to the deep dermis,[1] were 
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formed after severe burns and trauma because of abnormal 
wound repair, which was caused by the disorders of skin tissue 
structure. The undesirable physical properties of HS tissue can 
be attributed to the presence of a large amount of extracellular 
matrix (ECM) proteins. HSs were characterized by persistent 
inflammation, the excessive proliferation of fibroblasts, and 
the abnormal deposition of ECM proteins.[2-6] HSs not only 
deform the appearance of patients but also severely affect the 
body function and the psychological health of patients. HSs 
often cause lifelong disability, leading to a huge global public 
health burden.[7] Although some progresses have been achieved 
in HS treatment, it still remains a daunting problem both as a 
clinical and basic science issue.
A b s t r A c t
The formation of hypertrophic scars (HSs) is a fibroproliferative disorder of abnormal wound healing. HSs usually characterize 
excessive proliferation of fibroblasts, abnormal deposition of extracellular matrix (ECM) during wound healing, associated with 
cosmetic, functional, and psychological problems. Owing to the role of ECM proteins in scar formation, we comparatively analyzed 
matrix proteins secreted by normal skin fibroblasts (NSFs) and HS fibroblasts (HSFs). The acetone-extracted secreted proteins were 
separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), and identified by mass spectrometry (MS). 
Based on Go annotation of MS data, the profiling of ECM proteins was established and scar-related proteins have been screened 
out. The functions of several ECM proteins identified by MS have been discussed, such as collagens I, VI, XII, fibronectin, decorin, 
lumican, and protein procollagen C endopeptidase enhancer 1 (PCPE-1). Among them, the MS result of PCPE-1 was supported by 
Western blotting that PCPE-1 from HSFs were significantly upregulated than that from NSFs. It is suggested that PCPE-1 could be a 
potential target for scar treatment. The exploration of scar related proteins may provide new perspectives on understanding the 
mechanism of scar formation and open a new way to scar treatment and prevention.
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Among various scar formation factors, fibroblasts sustained 
activation and proliferation in wound repair. Fibroblast 
activation resulted in α-smooth muscle actin (α-SMA) 
expression.[8] The α-SMA level could be increased by the 
upregulation of  active transforming growth factor beta 
(TGF-β) 1 expression.[9] HS is principally associated with the 
overexpression of  TGF-β1,[10-12] which also inhibits ECM 
degradation by downregulating matrix metalloproteinase-1 
(MMP-1) and upregulating tissue inhibitors of  matrix me-
talloproteinases (TIMPs).[13] The synthesis and secretion 
of  excessive deposition of  collagen fibrils in ECM and the 
lower expression of  remodeling enzymes, including colla-
genase and MMPs, which mediates collagen degradation, 
is the biological basis of  scar formation. The understanding 
mechanism of  scar formation at molecular level may have a 
potential role in preventing and controlling scar formation, 
and relieving the economic burden of  suffered patients.
Mass spectrometry (MS) has been widely used in the 
quantitative and qualitative analysis of  a variety of  proteins 
and peptides, with the rapid development in experiment 
methods, data analysis, and ionization techniques.[14-16]
Most importantly, the introduction of  the soft ionization 
techniques, matrix-assisted laser desorption ionization 
(MALDI) and electrospray ionization (ESI),[17-20] has 
paved the way for MS-based proteomics. Some MS-based 
research related to wound healing or ECM proteins has 
been published.[21-24]
In this paper, our objectives were to identify ECM proteins 
secreted by normal skin fibroblasts (NSFs) and hypertro-
phic scar fibroblasts (HSFs) using MS-based methods, and 
establish the profiling of  ECM proteins. By comparison 
of  ECM proteins from NSFs and HSFs, scar-related 
proteins were screened out. The exploration of  scar-related 
proteins could open new perspectives for scar treatment 
and prevention.
Materials and methods
Human normal skin (NS) and hypertrophic scar (HS) samples
The protocols for human tissue sampling were approved by 
the Ethics Committee of  Southwest Hospital, Chongqing, 
China. HS patients were selected according to the Vancouver 
Scar Scale ranging from 10 to 13 score.[25] All patients were 
informed about the purpose and procedure of  this study and 
agreed to offer their tissue specimens with signed written 
consents. HS tissues were acquired from the patients under-
going orthopedic surgery at the Institute of  Burn Research 
of  the Third Military Medical University (TMMU). NS tis-
sues were acquired from the patients in the Department of  
 Urology, TMMU. After the removal of  subcutaneous fatty 
tissues using a scalpel, skin samples were stored in liquid 
nitrogen immediately till sample preparation.
Primary NSFs and HSFs
Fibroblasts from either NSFs or HSFs were isolated and 
cultured as follows: A piece of  skin tissue was put in a 
sterile Petri dish and washed three times with phosphate 
buffered saline (PBS). After the epidermis was removed 
using a pair of  sterile scissors, subcutaneous tissue was 
cut into 0.5 cm3 pieces and put into a 25 cm2 conical flask, 
then digested with 10 ml of  0.5% trypsin, and oscillated 
slightly 2 h at room temperature (RT). The digestion was 
terminated by adding of  10 ml Dulbecco’s modified 
Eagle’s medium (DMEM) containing 10% calf  serum 
(Hyclone, Rockfield, IL, USA). After the suspension 
passed through the sterile filter, the tissue fragments were 
discarded. The suspension was centrifuged at 400 g/
min for 10 min, and the supernatant was discarded. The 
suspension was washed 3 times with DMEM, and cen-
trifuged again. The supernatant was discarded, the cells 
were moved to a 75 cm2 flask, and cultured in DMEM 
supplemented with 10% calf  serum, 2 mM glutamine, 100 
U/ml penicillin, and 100 mg/ml streptomycin in air 5% 
CO
2
 at 37°C. After 24 h, the culture medium was changed, 
while less adherent cells were removed. The cells at 90% 
confluence were passaged. The cells from passage 5 to 7 
were used for the following experiments.
Proteins secreted by NSFs and HSFs
When the NSFs or HSFs from passage 5 to 7 reached 30% 
confluence, they were washed with PBS and grown with 
serum-free culture for 6 days. The culture supernatants from 
the same number of  fibroblasts were harvested, centrifuged 
at 3,000 rpm for 10 min at 4°C, and then precipitated with 
four volumes of  ice-cold acetone overnight at -20°C. The 
acetone precipitated samples were centrifuged at 12,000 
rpm for 30 min at 4°C, the supernatants were discarded, 
and the acetone leftover in the pellets was evaporated at 
RT. Finally, the extracted proteins from fibroblast culture 
supernatants were solved with lysis buffer, and the protein 
concentration was tested by Bradford (Thermo, Rockfield, 
IL, USA). The proteins in the lysis buffer were made into 
aliquots and saved at -80°C.
In-gel digestion
The extracted proteins were separated by 10% sodium 
dodecyl sulfate-polyacrylamide gel electrophoresis 
(SDS-PAGE) with coomassie blue staining. The SDS-
PAGE gel was manually cut into gel slices containing 
visible proteins. The gel slices were distained in 50 mM 
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 in 50% ethanol at 37°C for 30 min, then washed 




 (pH 8.0), and dehydrated with 
acetonitrile. After being dried in a SpeedVac, the gel slices 
were reduced with 10 mM dithiothreitol (DTT) for 1 h at 
56°C, and alkylated with 55 mM iodoacetamide containing 
6 M guanidine hydrochloride in a dark room for 45 min. 





dehydrated with acetonitrile, and dried in a SpeedVac con-





 containing 0.5 mg of  trypsin (modified 
sequencing grade; Promega, Madison, WI, USA) and 0.1% 
n-octyl glucoside (W/V) and digested at 37°C overnight. 
The peptides were extracted twice with 50 mL of  5% formic 
acid and 50% acetonitrile by sonication for 10 min, respec-
tively. The combined extracts were evaporated to about 2 mL 
in a SpeedVac and stored at -80°C for future MS analysis.
High performance liquid chromatography (HPLC)-chip-
tandem MS (MS/MS)
All nano-LC-MS/MS experiments were performed on an 
Agilent 6330 ion trap LC-MS/MS (Agilent Technologies, 
Santa, CA, USA). The system was equipped with an HPLC 
chip that was automatically located and positioned into 
the MS nanospray chamber. The chip contained a Zorbax 
300 SB-C18 (43 mm × 75 mm, 5 mm) column and a Zorbax 
300 SB-C18 (40 nL, 5 mm) enrichment column. The sample 
was loaded into the enrichment column at a flow rate of  
4 mL/min with 97% solvent A (H
2
O/0.1% formic acid (FA)) 
and 3% solvent B (90% acetonitrile (ACN)/10% H
2
O/0.1% 
FA). Tryptic peptides were eluted from the reversed phase 
column into the mass spectrometer using a linear gradient 
from 3% B to 45% B in 90 min and from 45% B to 90% B in 
10 min at a flow rate of  300 nL/min. The nanoelectrospray 
ion source was used with a spray voltage of  1.7-2.0 kV and 
the skimmer voltage was set at 40.0 V. The flow rate of  
drying gas nitrogen was 4 L/min with a gas temperature 
of  275°C. The fragmentation amplitude was 1.25 V. The 
SmartFrag was 30-200% out of  1.3 V. Positive ion mode was 
adopted at data-dependent mode with dynamic exclusion. 
Data between m/z 200 and 2,000 were recorded.
MS data processing
MS data were searched against the International Protein 
Index (IPI) human database (version 3.43) using the Agilent 
Spectrum Mill Server software. First, peak lists were created 
with the Spectrum Mill Data Extractor program under the 
following conditions: Scans with the same precursor ±1.4 
m/z were merged within a time frame of  ± 15 s. Precursor 
ions had a minimum signal to noise value of  25 with charges 
up to a maximum of 5. The 12C peak was determined by 
data extractor. The Spectrum Mill MS/MS was used to 
search against the IPI human database for tryptic peptides 
with a mass tolerance of  ±2.5 Da for the precursor ions 
and a tolerance of  ±0.7 Da for the fragment ions. Cysteine 
carboxymethylation and methionine oxidation was used as a 
fixed modification and a variable modification, respectively. 
Two missed cleavages were allowed. The Spectrum Mill 
autovalidation was performed first in the protein details 
mode and then in the peptide mode. Minimum scores, 
minimum scored peak intensity, forward minus reversed 
score threshold, and rank 1 minus rank 2 score threshold for 
peptides were dependent on the assigned precursor charge. To 
eliminate redundancy, the protein summary mode groups of  
all proteins that have at least one common peptide, and only 
the highest scoring member of  each protein group is shown 
and counted in the protein list.
Gene ontology (GO) annotation
Go annotation was performed on secreted proteins. The 
physiological process and function of these secreted proteins 
were analyzed. The results demonstrated these proteins 
were involved in multiple physiological processes including 
scar formation.
Western blotting
Equal amounts of  secreted proteins from NSF and HSF 
culture supernatants were transferred to poly(vinylidene fluo-
ride) (PVDF) membrane (Millipore, Billerica, MA, USA). 
The membrane was blocked with Tris–buffered saline (TBS) 
containing 5% non-fat powdered milk for 1 h at RT and then 
incubated with rabbit antihuman PCPE1 antibody (1:1200) 
at 4°C overnight. The membrane was subsequently washed 
with TBS containing 1% Tween 20, incubated with HRP-
labeled goat anti-rabbit secondary antibody (Boster, Wuhan, 
China, 1:2000) for 1 h at RT, washed and visualized with 
electrochemiluminescent (ECL) Western Blotting Detection 
Reagents (Pierce, Appleton, WI, USA).
Statistics
Statistical significance was evaluated using either a 2-tailed 
unpaired Student’s t test or nonparametric analysis if  the 
SDs were significantly different between the 2 groups being 
tested. Throughout the text, figures, and legends, the follow-
ing symbols are used to denote statistical significance: * P < 
0.05; ** P < 0.01.
Results
GO analysis of secreted proteins from NSFs and HSFs
The tryptic digested peptides were characterized by HPLC-
chip-MS/MS. A total of  82 and 79 proteins were identified 
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from the proteins secreted by NSFs and HSFs, of  which 36 
proteins from NSFs and 34 proteins from HSFs were anno-
tated as ECM proteins by GO analysis, respectively. Totally, 
49 proteins were identified from both cells. Among ECM 
proteins, 21 common proteins [Table 1] were from both cells, 
13 specific proteins from HSFs [Table 2], and 15 specific 
proteins from NSFs [Table 3]. Several MS/MS spectra from 
four identified peptides have been shown in Figure 1.
As for the components of  ECM proteins, it can be seen in 
Figure 2a that matrix proteins are mainly from extracellular 
region, extracellular region part, and cell parts. A total of  
13 biological processes related to ECM proteins are shown 
in Figure 2b. The processes mainly include cellular process 
and biological function, response to stimulus, developmen-
tal process, and multicellular organismal process. Figure 2c 
shows the functional analysis of  ECM proteins. It can be 
seen that ECM proteins involved in binding function ac-
count for 81.8 (NSFs) and 85.3% (HSFs), respectively.Table 1: Twenty-one commonly secreted proteins from NSFs 
and HSFs
Protein definition Accession number pI MW
Adipocyte enhancer-binding protein 1 IPI00745313 5.05 130,929
Collagen α-1(I) IPI00297646 5.61 138,912
Collagen α-1(VI) IPI00291136 5.26 108,530
Collagen α-3(VI) IPI00022200 6.27 343,671
Collagen α-1(XII) IPI00329573 5.38 333,148
Type IV collagenase IPI00027780 5.26 73,883
Complement C1r subcomponent IPI00296165 5.89 80,174
Complement C3 IPI00783987 6.02 187,149
EGF-containing fibulin-like extracellular 
matrix protein 1
IPI00029658 4.95 54,641
Fibronectin IPI00414283 5.53 256,513
Galectin-3-binding protein IPI00023673 5.13 65,331
Glia-derived nexin IPI00009890 9.35 44,003
Laminin subunit α-4 IPI00329482 5.90 202,529
Laminin subunit γ-1 IPI00298281 5.01 177,608
α-2-macroglobulin IPI00478003 6.00 163,279
Pappalysin-1 IPI00001869 5.78 181,142
Pentraxin-related protein PTX3 IPI00029568 4.90 42,020
Plasma protease C1 inhibitor IPI00291866 6.09 55,155
Plasminogen activator inhibitor 1 IPI00007118 6.67 45,060
Sulfhydryl oxidase 1 IPI00003590 9.13 82,578
Transforming growth factor-β-induced 
protein ig-h3
IPI00018219 7.62 74,681
NSF = Normal skin fibroblast, HSF = Hypertrophic scar fibroblasts, MW = Molecular 
weight, pI = Isoelectric point, EGF = Epidermal growth factor
Table 2: Fifteen specific secreted proteins from NSFs
Protein definition Accesstion number pI MW
Antithrombin-III IPI00032179 6.12 52,692
Apolipoprotein A-I IPI00021841 5.56 30,778
Collagen α-2(VI) chain IPI00304840 5.85 108,580
Complement C4-B IPI00654875 6.74 192,795
α-fetoprotein IPI00022443 5.48 68,678
Ficolin-3 IPI00293925 6.20 32,903
Histidine-rich glycoprotein IPI00022371 7.09 59,579
Interleukin-1 family member 10 IPI00103482 4.95 16,943
Lumican IPI00020986 6.16 38,429
Nidogen-1 IPI00026944 5.14 136,454
Nidogen-2 IPI00028908 5.08 151,396
Peroxidasin homolog IPI00016112 6.79 165,276
Thyroxine-binding globulin IPI00292946 5.87 46,325
Inter-α-trypsin inhibitor heavy chain H1 IPI00292530 6.31 101,390
Vitronectin IPI00298971 5.55 54,306
NSF = Normal skin fibroblast, MW = Molecular weight, pI = Isoelectric point
Figure 1: MS/MS spectra of the peptides from identified extracellular 
matrix (ECM) proteins corresponding to (a) the procollagen C 
endopeptidase enhancer 1 (PCPE-1) peptide (YDALEVFAGSGTSGQR), 
(b) the decorin peptide (DFEPSLGPVCPFR), (c) the fibronectin 
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Table 3: Thirteen specific secreted proteins from HSFs
Protein definition Accession number pI MW
Cathepsin B IPI00295741 5.88 37,822
Complement C1s subcomponent IPI00017696 4.86 76,685
Interstitial collagenase IPI00008561 6.47 54,007
Decorin IPI00012119 8.75 39,747
Ectonucleotide pyrophosphatase/
phosphodiesterase family member 2
IPI00303210 8.50 105,212
Fibulin 1 IPI00296534 5.11 77,262
Follistatin-related protein 1 IPI00029723 5.39 34,986
78 kDa glucose-regulated protein IPI00003362 5.07 72,422
Pigment epithelium-derived factor IPI00006114 5.97 46,343
Procollagen C-endopeptidase enhancer 1 IPI00299738 7.41 47,973
Stromelysin-1 IPI00027782 5.77 53,978
Tumor necrosis factor receptor 
superfamily member 11B
IPI00298362 8.71 46,040
WAP four-disulfide core domain protein 5 IPI00152461 8.40 24,238
HSF = Hypertrophic scar fibroblasts, MW = Molecular weight, pI = Isoelectric point
Figure 2: Gene ontology (GO) analysis of extracellular matrix (ECM) 
proteins secreted by normal skin fibroblasts (NSFs) and hypertrophic 
scar fibroblasts (HSFs), with (a) component annotation, (b) process 
annotation, and (c) activity annotation. Fibroblast culture supernatants 
were collected at 90% confluence between passage 5 and 7. Red bar 
stands for NSF and blue bar stands for HSF.
Molecular weight (MW) and isoelectric point (pI) dependence 
of ECM proteins
The MW distribution of  ECM proteins is shown in 
Figure 3a. Fifty and 62% of  ECM proteins secreted 
by NSFs and HSFs have MWs in the range of  30-100 
kDa, respectively. More proteins from NSFs (47%) have 
MW > 100 kDa than those from HSFs (35%). The pI 
distribution of  ECM proteins over a range of  3-10 is shown 
in Figure 3b. Eighty-nine percent proteins from NSFs and 
76% proteins from HSFs are located at pI < 7; 6% proteins 
from both cells at pI 7-8; fewer proteins from NSFs (6%) 
at pI > 8 than those from HSFs (18%). The pI distributions 
with MW of  NSFs and HSFs are shown in Figure 3c and d.
Verification of PCPE-1 by Western blotting
PCEP-1 was significantly higher expressed in the culture 
supernatant of  HSFs than in that of  NSFs by Western 
blotting [Figure 4].
Discussion
HS formation is a dermal fibroproliferative disorder of  
human dermis, leading to considerable morbidity. ECM 
proteins play pivotal biological regulatory roles and are the 
most important sources for protein therapeutics. Therefore, 




Figure 3: Molecular weight (MW) and isoelectric point (pI) distribution of 
extracellular matrix (ECM) proteins secreted by normal skin fibroblasts 
(NSFs) and hypertrophic scar fibroblasts (HSFs). (a) ECM proteins have 
been grouped into different MW bins according to their theoretical size. 
(b) ECM proteins have been grouped into different pI bins according 
to their theoretical value. Red bar stands for NSF and blue bar stands 
for HSF. (c and d) MW distributions of ECM proteins from NSFs and 
HSFS were plotted against their theoretical pIs, respectively.
a b
c d
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may provide new perspectives on HS formation and treat-
ment. ECM contains many adhesive proteins, including 
fibronectin, collagen, and laminin, which generally promote 
cell attachment or migration.[6] Collagens stand for a large 
family of  ECM proteins. Collagen fibril networks are stabi-
lized by their interaction with proteoglycans and/or other 
collagenous and noncollagenous proteins. The synthesis 
ability of  collagen in HSFs is obviously enhanced than that 
in NSFs, resulting in the excess synthesis and deposition of  
collagen. Excessive collagen deposition is related not only 
to increased collagen synthesis, but also to reduced collagen 
degradation. Compared pathological scars with NSs, the 
activity of  fibroblast collagenase was significantly reduced, 
while the messenger ribonucleic acid (mRNA) levels of  col-
lagenase decreased significantly.[26]
It is shown from Figure 3 that the tendency of  pI distribu-
tion of  identified ECM proteins from NSFs and HSFs is in 
agreement with reported research.[27] This means that the 
identification of  ECM proteins from fibroblasts is efficient. 
We identified major known ECM components, collage I and 
VI, laminin, fibronectin, decorin, and lumican [Figure 1], 
though some proteins were not detected by LC-chip-MS/
MS, for example, elastin, collagen III and IV, and other 
proteoglycans. Some known proteins were not detected 
could be those reasons: The protein amount is not large 
enough to be identified with our instrument; some proteins 
are glycosylated or cross-linked, and could not be efficiently 
digested. For example, the formation of  intermolecular 
Figure 4: Procollagen C endopeptidase enhancer 1 (PCPE-1) expression 
secreted by normal skin fibroblasts (NSFs) and hypertrophic scar 
fibroblasts (HSFs) was validated by Western blotting (n = 3; * *P < 0.01).
covalent bonds among elastin molecules will prevent the 
digestion and solubilization of  elastin. Additionally, more 
proteins would be detected if  a more sensitive high quality 
mass spectrometer available. However, based on GO anno-
tation, these matrix proteins are still involved 12 biological 
processes and eight activities.
Herein, collagens I, VI, XII and fibronectin were identified 
in both cell culture supernatants. Collagen VI is a non-
fibrillar collagen. In collagen VI null mice, dysfunctional 
regulation of  tendon fibrillogenesis was indirectly medi-
ated by collagen VI.[28] Collagen XII has been classified as 
a fibril-associated collagen with interrupted triple helices 
(FACTs) and is bound to the surface of  collagen I fibrils,[29] 
a fibril-forming protein. Collagen XII is a novel candidate 
marker of  myofibroblasts, and/or cancer cells undergoing 
dedifferentiation.[30] Cancer-associated fibroblasts present a 
myofibroblastic phenotype, similar to the one obtained by 
resident fibroblasts during wound healing. Collagen XII can 
interact with various other ECM proteins like decorin and 
tenascin-X via distinct or overlapping domains.[31]
Fibronectin is a large ECM glycoprotein with a MW of  
440 kDa and exists as a protein dimer. Fibronectin not 
only binds to membrane-spanning receptor proteins called 
integrins, but also binds with ECM protein such as collagen, 
fibrin, and syndecans.[32] Fibronectin regulates dermal fibro-
blast cell behavior during wound repair. The fragmentation 
of  fibronectin by proteases has been suggested to promote 
wound contraction, a critical step in wound healing. Fibro-
nectin helped the deposition of  collagen in the wounded site 
and was observed to be closely associated with the newly 
deposited collagen fibrils. An in vitro study with native col-
lagen has demonstrated that fibronectin bound to collagen 
III.[33] Fibronectin also regulated latent TGF-β1 by control-
ling matrix assembly of  latent TGF-β1-binding protein-1.[34]
A large number of  noncollagenous ECM proteins have been 
implicated in regulating collagen fibrillogenesis, including 
small leucine-rich repeat proteoglycans (SLRPs) like decorin 
and lumican. Lumican and decorin was founded in NSF and 
HSF culture supernatants, respectively. Decorin was found in 
HSFs consistent with the view that decorin at the messenger 
RNA and protein level was significantly higher in the skin 
lesions of  patients with nephrogenic systemic fibrosis than 
healthy subjects.[35] Decorin is a natural anticancer agent and 
reduced level of  decorin was associated with more aggres-
sive disease, such as tumorigenesis, tumor invasion, and/or 
tumor growth.[36,37] Interestingly, lumican plays a restrictive 
role on prostate cancer progression, and it is postulated that 
lumican could be a valuable marker in prostate cancer stag-
ing.[37] Interestingly, HSFs exhibit excessive proliferation, 
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ECM proteins were discussed in detail. PCPE-1 was found 
to be related to scar formation, and might be a new target 
for scar treatment. Some scare related ECM proteins could 
open new perspectives for understanding the mechanism of  
scar formation and provide new methods for scar treatment.
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apoptosis resistance, and atypical differentiation, which 
are the  characteristics of  malignant tumors. This maybe 
explained why some scar-related proteins also affect cancer 
progression. Because of the limitation of the used mass spec-
trometer and the differentiation from sample preparation, 
the proteins observed in HSFs or NSFs can only stand for 
more proteins appeared in MS, and is a primary proteomic 
profiling of  scar-related proteins and further quantitative 
proteomic analysis need to be carried out.
Here, we elaborated a potential role of  protein procollagen 
C endopeptidase enhancer 1 (PCPE-1) in HS formation. 
PCPE-1, a 55-kDa ECM glycoprotein without intrinsic 
proteolytic activity, containing two N-terminal CUB 
(complement-Uegf-BMP1) domains and a C-terminal NTR 
(netrin-like) domain, was found to be one of  proteins related 
to fibrosis,[38,39] but no mass-based studies have reported on 
the relationship between PCPE-1 and skin fibrosis so far. 
The CUB domains of  PCPE-1 can bind specifically to type I 
procollagen C propeptides leading to potential fibrosis, while 
the NTR domains of  PCPE-1 may inhibit matrix-degrading 
proteinases.[40] PCPE-1 can enhance the activity of  procol-
lagen C proteinases (PCPs) significantly. The activity of  
PCPs is necessary for the conversion of  soluble procollagen 
into the complete formation of  collagen fibrils.[41] PCPs can 
cleave the C propeptides of  procollagen I to III and the N-
propeptides of  procollagen V, which can cause fibrosis, and 
this is an important step for assembling the major fibrous 
components of  vertebrate ECM.[39,42] During scar formation, 
TGF-β was highly expressed in HSFs, whereas, TGF-β can 
increase the PCP expression. In the process of  scar forma-
tion, the higher expression of  PCPE can cause the increase 
of  procollagen into collagen fibrils; Secondly, the markable 
increase of  PCPE-1 in HSF culture supernatants would 
reduce the production of  matrix-degrading proteinases. All 
together, the increase of  PCPE-1 promoted scar formation. 
Our MS results of  PCPE-1 was supported by Western blot-
ting [Figure 4] and that the amount of  PCPE-1 from HSFs 
was much more than that from NSFs, whereas, the function 
of  PCPE-1 in scar formation still needs further study. No 
matter what mechanism PCPE-1 has, it plays a vital role in 
scar formation. Thus, to control the production of  PCPE-1 
may provide new insights into scar treatment.[43]
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tively. By comparing ECM proteins from both cells, scar-relat-
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